Viking Therapeutics Inc. (VKTX) Podcasts

1 episode across The Earnings Debate

Viking Therapeutics, Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "a net loss of $158.3 million or $1.37 per share" artwork

Viking Therapeutics, Inc. Announced Q1 2026 Earnings on April 29, 2026, Reporting "a net loss of $158.3 million or $1.37 per share"

Apr 30, 2026 • 20:54 •Ep 113 •The Earnings Debate •▶ Play on Apple

BiotechnologyPharmaceuticalsCardiometabolicVK2735